Browse by Phase
Phase 3 Clinical Trials
Phase 3 trials compare a new drug or treatment against the current standard of care in a large population (300–3,000+ participants). Successful Phase 3 results are the basis for regulatory approval.
Total Trials
514
Recruiting Now
514
Top Conditions in Phase 3
NCT04683003 Phase 3
Recruiting
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic P...
Condition
Thrombotic Thrombocytopenic Purpura (TTP)
Enrollment
77 pts
Location
United States, Austria, China
Sponsor
Takeda
NCT06697886 Phase 3
Recruiting
A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Commo...
Condition
Common Cold
Enrollment
480 pts
Location
China
Sponsor
Tasly Pharmaceutical Group Co.
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT06039566 Phase 3
Recruiting
NAC vs Placebo on Opioid Use for Hysterectomy
Condition
Hysterectomy
Enrollment
240 pts
Location
United States
Sponsor
Medical University of South Ca
NCT06774131 Phase 3
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract...
Condition
Upper Urinary Tract Urothelial Carcinoma
Enrollment
70 pts
Location
United States, Bulgaria, Georgia
Sponsor
UroGen Pharma Ltd.
NCT05717725 Phase 3
Recruiting
Pulsed-field Ablation Vs. Sham Ablation to Treat AF
Condition
Atrial Fibrillation
Enrollment
60 pts
Location
Czechia
Sponsor
Charles University, Czech Repu
NCT07456696 Phase 3
Recruiting
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (...
Condition
Post Traumatic Stress Disorder
Enrollment
300 pts
Location
United States
Sponsor
Transcend Therapeutics
NCT06765161 Phase 3
Recruiting
Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
Condition
Myasthaenia Gravis
Enrollment
30 pts
Location
Canada
Sponsor
Clinique Neuro-Outaouais
NCT05586802 Phase 3
Recruiting
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndro...
Condition
Klinefelter Syndrome
Enrollment
150 pts
Location
Switzerland
Sponsor
Georgios Papadakis
NCT05716880 Phase 3
Recruiting
Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome
Condition
Nephrotic Syndrome
Enrollment
150 pts
Location
Poland
Sponsor
Military Institute od Medicine
NCT06701396 Phase 3
Recruiting
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Di...
Condition
Sleep Wake Disorders
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Vanda Pharmaceuticals
NCT06847542 Phase 3
Recruiting
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizum...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
250 pts
Location
Austria, Czechia, Denmark
Sponsor
Hoffmann-La Roche
NCT07307586 Phase 3
Recruiting
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinica...
Condition
Chronic Hepatitis B
Enrollment
120 pts
Location
China
Sponsor
Zhigang Ren
NCT07024173 Phase 3
Recruiting
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Adv...
Condition
Locally Advanced Breast Cancer
Enrollment
240 pts
Location
China
Sponsor
Shandong Suncadia Medicine Co.
NCT05456503 Phase 3
Recruiting
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-262...
Condition
Frontotemporal Lobar Degeneration
Enrollment
72 pts
Location
United States
Sponsor
University of Pennsylvania
NCT06336824 Phase 3
Recruiting
Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aure...
Condition
Staphylococcus Aureus Bacteremia
Enrollment
290 pts
Location
Malaysia
Sponsor
Clinical Research Centre, Mala
NCT06623123 Phase 3
Recruiting
Oto Smartphone App in Treating Tinnitus Amongst Adult Patients Compared with Sta...
Condition
Tinnitus
Enrollment
160 pts
Location
United Kingdom
Sponsor
East and North Hertfordshire N
NCT06630923 Phase 3
Recruiting
PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PA...
Condition
Diuretics Drug Reactions
Enrollment
250 pts
Location
Greece
Sponsor
Democritus University of Thrac
NCT07281079 Phase 3
Recruiting
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
Condition
Phelan-McDermid Syndrome
Enrollment
160 pts
Location
United States
Sponsor
Neuren Pharmaceuticals Limited
NCT07465705 Phase 3
Recruiting
Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a ...
Condition
Elective Colonoscopy
Enrollment
412 pts
Location
Belgium, Italy, Poland
Sponsor
NTC srl
NCT06510764 Phase 3
Recruiting
A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture f...
Condition
Precocious Puberty
Enrollment
170 pts
Location
China
Sponsor
Children's Hospital of Fudan U
NCT07261644 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active...
Condition
Ankylosing Spondylitis
Enrollment
500 pts
Location
China
Sponsor
Sunshine Guojian Pharmaceutica
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT05462704 Phase 3
Recruiting
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
Condition
Iron Deficiency Anemia
Enrollment
300 pts
Location
United States
Sponsor
Women and Infants Hospital of